Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Pfizer Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 6 October 2026, 9:18 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price3,852₹ per share
Reported P/E22.9Times
Book value per share919₹ per share
Reported ROCE24.1 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 6 October 2026, 9:18 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap17,633 Cr.
Current Price3,852
High / Low5,578/3,792
Stock P/E22.9
Book Value919
Dividend Yield1.95 %
ROCE24.1 %
ROE18.0 %
Face Value10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Pfizer Ltd 17,633 Cr. 3,852 5,578/3,79222.9 9191.95 %24.1 %18.0 % 10.0
Cohance Lifesciences Ltd 17,487 Cr. 457 918/267162 1020.00 %5.81 %4.89 % 1.00
ERIS Lifesciences Ltd 16,459 Cr. 1,185 1,740/1,16325.1 2820.61 %14.1 %18.7 % 1.00
Alembic Pharmaceuticals Ltd 16,399 Cr. 834 998/63522.0 2891.44 %12.6 %13.4 % 2.00
Natco Pharma Ltd 16,145 Cr. 824 1,217/78614.1 4700.61 %17.4 %17.1 % 2.00
Industry Average17,635.87 Cr1,251.0754.95211.240.39%26.16%16.59%6.06

All Competitor Stocks of Pfizer Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 531575540547563589538592603642645629653
Expenses 421393387357385399392364393412417393406
Operating Profit 111183153189177189146228210230228236248
OPM % 21%32%28%35%32%32%27%38%35%36%35%38%38%
Other Income 333644754243432176742-205045
Interest 3337222332221
Depreciation 16151814151515161414141514
Profit before tax 126201176244203215172426260255192269277
Tax % 26%26%26%27%26%26%26%22%26%26%26%26%26%
Net Profit 94149130179151158128331192189142200204
EPS in Rs 20.4432.5628.4139.1032.9434.6127.8972.3441.9141.3231.0043.6844.70

Last Updated: September 29, 2026, 6:27 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 26, 2026, 9:02 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 1,1121,8532,0121,9661,9692,0822,1522,2392,6112,4252,1932,2812,5202,570
Expenses 8721,4381,5791,6161,4681,5161,5781,5261,7751,6161,5551,5401,6151,628
Operating Profit 239414433350501566574712836809638742904942
OPM % 22%22%22%18%25%27%27%32%32%33%29%33%36%37%
Other Income 10944972321141671838163134185344139116
Interest 12121211151113158108
Depreciation 82505863667110310911510662615858
Profit before tax 3402074705175486606426697738247461,016976993
Tax % 35%66%35%35%34%35%21%26%21%24%26%24%26%
Net Profit 22170305337360429509498613624551768722735
EPS in Rs 74.0115.2666.6773.6278.7193.79111.29108.77133.90136.38120.52167.79157.92160.70
Dividend Payout % 486%82%22%27%25%24%297%32%26%29%29%98%48%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)-68.33%335.71%10.49%6.82%19.17%18.65%-2.16%23.09%1.79%-11.70%39.38%-5.99%
Change in YoY Net Profit Growth (%)0.00%404.04%-325.22%-3.67%12.34%-0.52%-20.81%25.25%-21.30%-13.49%51.08%-45.37%

Pfizer Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Last Updated: September 5, 2025, 12:15 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 6, 2026, 9:18 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 464646464646464646464646
Reserves 1,9272,1182,3732,6372,9663,3502,3472,8193,1623,5504,1724,157
Borrowings 2222226339414010870
Other Liabilities 6387228401,0049261,007810997752593585649
Total Liabilities 2,6142,8883,2613,6903,9404,4053,2663,9014,0014,2294,9114,922
Fixed Assets 944925902950886973894869749713724678
CWIP 133151-013180820
Investments 4337-0-0-0-0-0-0-0-0-0-0
Other Assets 1,6141,9232,3432,7393,0543,4322,3693,0303,2443,5164,1804,224
Total Assets 2,6142,8883,2613,6903,9404,4053,2663,9014,0014,2294,9114,922
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 11334532933298323427667356257660968
Cash from Investing Activity + 68-701-250-238351,530-469-575-3654-71-562
Cash from Financing Activity + -1-62-83-110-110-164-1,571-181-346-235-205-798
Net Cash Flow 181-417-3-17231,690-1,613-88-2675383-392
Free Cash Flow 93398394262125343410654292291783944
CFO/OP 62%120%146%105%59%93%89%107%81%64%110%105%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow93.00398.00394.00262.00125.00343.00410.00654.00292.00291.00783.00944.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 573226202930291820233131
Inventory Days 148191167148147189198199173175200214
Days Payable 156165157178245213197130102917768
Cash Conversion Cycle 495836-10-696318791107154177
Working Capital Days 257-9-47-57-16-83-14-42423
ROCE %29%24%22%17%21%23%20%23%29%26%22%22%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 63.92%63.92%63.92%63.92%63.92%63.92%63.92%63.92%63.92%63.92%63.92%63.92%
FIIs 2.82%3.03%3.32%3.22%3.54%2.74%2.18%2.40%2.60%2.71%2.81%1.65%
DIIs 15.00%15.15%15.32%15.83%16.03%16.80%17.10%17.23%17.11%17.05%16.89%17.80%
Public 18.24%17.87%17.42%17.00%16.50%16.54%16.79%16.45%16.37%16.32%16.36%16.62%
No. of Shareholders 1,16,9481,12,4561,09,2141,06,09898,8241,05,0151,08,2611,03,2221,03,4801,00,93399,5451,02,478
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Nippon India Small Cap Fund 1,206,103 0.84 550.42947,9102025-12-08 07:42:1327.24%
Quant Small Cap Fund 914,527 1.52 417.35875,0272025-12-15 09:05:474.51%
ICICI Prudential Smallcap Fund 365,366 2.05 166.74360,0002026-02-22 10:27:061.49%
Nippon India Multi Cap Fund 358,673 0.34 163.68362,8482026-02-22 10:27:06-1.15%
ICICI Prudential Value Fund 356,622 0.27 162.75347,0012026-02-23 07:11:392.77%
Nippon India Pharma Fund 318,249 1.84 145.24293,2492025-12-08 04:19:428.53%
UTI Mid Cap Fund 250,000 0.99 114.09246,2762026-02-23 02:04:121.51%
DSP Healthcare Fund 200,644 3.08 91.57N/AN/AN/A
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 180,970 1.24 82.59N/AN/AN/A
DSP Large & Mid Cap Fund 178,101 0.47 81.28N/AN/AN/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 136.46120.51128.50133.89108.77
Diluted EPS (Rs.) 167.79120.51136.38133.89108.77
Cash EPS (Rs.) 181.07134.12159.44159.03132.68
Book Value[Excl.RevalReserv]/Share (Rs.) 921.84785.91701.05626.10523.07
Book Value[Incl.RevalReserv]/Share (Rs.) 921.84785.91701.05626.10523.07
Dividend / Share (Rs.) 165.0035.0070.0035.0035.00
Revenue From Operations / Share (Rs.) 498.65479.38530.00570.71489.30
PBDIT / Share (Rs.) 199.45178.32198.89196.37173.38
PBIT / Share (Rs.) 186.16164.71175.82171.23149.47
PBT / Share (Rs.) 222.10163.07180.11168.94146.17
Net Profit / Share (Rs.) 167.78120.51136.38133.89108.77
PBDIT Margin (%) 39.9937.1937.5234.4035.43
PBIT Margin (%) 37.3334.3533.1730.0030.54
PBT Margin (%) 44.5334.0133.9829.6029.87
Net Profit Margin (%) 33.6425.1325.7323.4622.22
Return on Networth / Equity (%) 18.2015.3319.4521.3820.79
Return on Capital Employeed (%) 19.6120.4624.0525.7027.44
Return On Assets (%) 15.6213.0315.5915.7015.23
Asset Turnover Ratio (%) 0.490.530.610.720.58
Current Ratio (X) 6.175.073.842.812.49
Quick Ratio (X) 5.334.273.212.281.92
Inventory Turnover Ratio (X) 5.020.780.790.800.77
Dividend Payout Ratio (NP) (%) 20.8633.1947.6526.13303.38
Dividend Payout Ratio (CP) (%) 19.3329.8240.7622.00248.70
Earning Retention Ratio (%) 79.1466.8152.3573.87-203.38
Cash Earning Retention Ratio (%) 80.6770.1859.2478.00-148.70
Interest Coverage Ratio (X) 108.5052.9467.9585.6452.50
Interest Coverage Ratio (Post Tax) (X) 71.7236.2645.1359.3933.93
Enterprise Value (Cr.) 15519.5917140.8213990.3218276.3719572.81
EV / Net Operating Revenue (X) 6.807.825.777.008.74
EV / EBITDA (X) 17.0121.0115.3820.3424.67
MarketCap / Net Operating Revenue (X) 8.038.756.547.629.24
Retention Ratios (%) 79.1366.8052.3473.86-203.38
Price / BV (X) 4.345.344.946.958.64
Price / Net Operating Revenue (X) 8.038.756.547.629.24
EarningsYield 0.040.020.030.030.02
Advertisements
Explore Industry-wise Company financial data